35986841_10216840653711318_1105697261150535680_n
Amazon cover image
Image from Amazon.com

Artificial cells : biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy / Thomas Ming Swi Chang.

By: Material type: TextTextSeries: Regenerative medicine, artificial cells and nanomedicine ; v. 1Publication details: Hackensack, N. J. : World Scientific, c2007.Edition: 1st edDescription: xxvi, 455 p. : ill. (some col.) ; 24 cmISBN:
  • 9789812705761 (hardcover)
  • 9812705767 (hardcover)
  • 9789812707789 (pbk.)
  • 9812707786 (pbk.)
Subject(s): DDC classification:
  • 615.39 22
LOC classification:
  • RM171.7 .C478 2007
NLM classification:
  • WH 450
Online resources:
Contents:
50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Books Books Centeral Library Second Floor - Biotechnology 615.39 C.T.A 2007 (Browse shelf(Opens below)) Available 16176

Includes bibliographical references (p. 377-440).

50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.

There are no comments on this title.

to post a comment.